Authors:
GULBA DC
PRAUS M
DECHEND R
HAUCK S
MAHLER M
ZITVZ R
BALDUS B
MULLER W
DIETZ R
Citation: Dc. Gulba et al., UPDATE ON THE TOXICOLOGY AND PHARMACOLOGY OF RDSPA ALPHA-1 (BAT-PA) IN ANIMALS AND HUMANS, Fibrinolysis & proteolysis, 11, 1997, pp. 55-62
Citation: M. Praus et al., MODULATION OF TUMOR-METASTASIS BY ADENOVIRAL MEDIATED GENE-TRANSFER OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITORS, Cancer gene therapy, 4(5), 1997, pp. 298-298
Authors:
DECHEND R
MO X
SCHULZ W
GROSS M
PRAUS M
DIETZ R
GULBA DC
Citation: R. Dechend et al., THROMBIN RECEPTOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE COLOCALIZED IN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM HUMAN CAROTID ATHEROSCLEROTIC PLAQUES, Fibrinolysis, 10, 1996, pp. 41-45
Authors:
DECHEND R
SELBIG D
PRAUS M
HAUCK S
DIETZ R
GULBA DC
Citation: R. Dechend et al., LONG-TERM THROMBOLYTIC THERAPY WITH 2 NEW RT-PA REGIMEN IN SUBMASSIVEPULMONARY-EMBOLISM - RESULTS OF A PILOT-STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1108-1108
Citation: Dc. Gulba et al., DSPA-ALPHA - PROPERTIES OF THE PLASMINOGEN ACTIVATORS OF THE VAMPIRE BAT DESMODUS-ROTUNDUS, Fibrinolysis, 9, 1995, pp. 91-96
Authors:
PRAUS M
MO XM
GROSSE Y
BALDUS B
MORSER J
DECHEND R
GULBA DC
Citation: M. Praus et al., A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS, Circulation, 92(8), 1995, pp. 2989-2989
Authors:
DECHEND R
HAUCK S
EICHHORN J
GOEDECKE W
PRAUS M
SCHULZMENGER J
BARTHELS M
DIETZ R
GULBA DC
Citation: R. Dechend et al., EFFECTS OF LOW-MOLECULAR-WEIGHT AND HIGH-MOLECULAR-WEIGHT HEPARIN ON THE INTRINSIC AND EXTRINSIC ENDOGENOUS FIBRINOLYTIC SYSTEM, Fibrinolysis, 8, 1994, pp. 71-74